kabutan

Soiken Holdings Inc.(2385) Summary

2385
TSE Growth
Soiken Holdings Inc.
247
JPY
-3
(-1.20%)
Apr 13, 1:59 pm JST
1.54
USD
Apr 13, 12:59 am EDT
Result
PTS
outside of trading hours
248
Apr 13, 2:06 pm JST
Summary Chart Historical News Financial Result
PER
214.7
PBR
1.07
Yield
4.05%
Margin Trading Ratio
Stock Price
Apr 13, 2026
Opening Apr 13, 9:00 am
252 JPY 1.57 USD
Previous Close Apr 10
250 JPY 1.56 USD
High Apr 13, 9:14 am
253 JPY 1.58 USD
Low Apr 13, 11:20 am
247 JPY 1.54 USD
Volume
29,800
Trading Value
7.00M JPY 0.05M USD
VWAP
249.47 JPY 1.56 USD
Minimum Trading Value
24,700 JPY 154 USD
Market Cap
6.46B JPY 0.04B USD
Number of Trades
43
Liquidity & Number of Trades
As of Apr 13, 2026
Liquidity
Mid
1-Year Average
220
1-Year High Dec 1, 2025
9,730
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 3, 2026 0 843,600
Mar 27, 2026 0 888,600
Mar 19, 2026 0 970,900
Mar 13, 2026 0 986,300
Mar 6, 2026 0 1,004,300
Company Profile
Soiken Holdings Inc. is a venture business originating from Osaka University. The company's main focus is on cosmetics, but it also engages in functional food evaluation testing and anti-fatigue food products.
Sector
Services
Soiken Holdings Inc. was established as a biotech venture from Osaka University and operates in five business areas: bio-evaluation systems, healthcare support, cosmetics, health supplements, and functional ingredient development. In the bio-evaluation systems business, the company conducts evaluation tests using biomarkers and supports clinical research for pharmaceuticals. The healthcare support business offers services such as health checkups, specific health guidance, and diabetes severity prevention programs. The cosmetics business develops and markets its own brand using placenta extract. In the health supplements business, "Imida Peptide" is sold as the main product. The functional ingredient development business focuses on developing and selling functional materials such as lactoferrin.